Skip to main content

IGM Biosciences, Inc.

IGMSDelisted Aug 14, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001496323

IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding IGM Biosciences, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of IGMS: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders8275−7
Shares18.0M17.9M−125.4K (−0.7%)
Value$305.8M$245.4M−$60.3M (−19.7%)

New holders (7)

Institutions that held IGM Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to IGMS in Q1 2023
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.129,740$1.78M0.01%
Tudor Investment Corp Et Al14,497$199.0K0.00%
Jane Street Group, LLC13,630$187.3K0.00%
Two Sigma Investments, LP11,400$156.6K0.00%
Invesco Ltd.10,490$144.1K0.00%
Point72 Middle East FZE2,569$35.3K0.00%
Cubist Systematic Strategies, LLC2,189$30.1K0.00%

Sold out (14)

Institutions that held IGM Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.